Cognitive Research
Dihexa
BioHarmony verdict
Caution
Dihexa is a gray-market angiotensin IV analog with rodent synaptogenesis and memory data, including McCoy 2013 and Sun 2021, but zero human trials, no human pharmacokinetics, and FDA-noted absence of human exposure data.
Read full reportWhat is Dihexa?
Dihexa is a synthetic angiotensin IV analog developed as a procognitive research compound. The basic claim is simple: dihexa may help neurons form new synapses by potentiating hepatocyte growth factor signaling at the c-Met receptor, with AT4 / IRAP biology connecting the angiotensin system to memory-related pathways.
From the BioHarmony report, reviewed 2026-09-08.
How it is thought to work
Potentiates hepatocyte growth factor signaling at c-Met and is claimed to increase dendritic spine formation and synapse assembly in hippocampal tissue.
Safety watch-outs
- Severe agitation, mania, or insomnia
- New neurological symptoms
Full risk profile in the BioHarmony report.
Dosing as published
No approved-label or study protocol is recorded for Dihexa yet.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Educator coverage (3)
Attributed viewpoints, separate from primary research.
- Peptides to Promote Cellular HealthDr. Suzanne Ferree · 2025-09-15
- Dihexa: A Deep Dive on the Synapse Building Nootropic PeptideHunter Williams · 2026-03-30
- Dihexa Benefits, Dosage and Side EffectsJay Campbell · 2026-04-29
Trust & sourcing
FDA says it has not identified human exposure data for dihexa acetate and lacks enough information to determine whether administration would cause harm.
Primary sources
- Certain bulk drug substances for use in compounding that may present significant safety risksU.S. Food and Drug Administration · 2026-04-22
Related peptides for brain, mood & sleep
Free guide
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.